Table 1.
First Author |
Last Author |
Publication Year |
Radioligand | ICB Type | Method | Significant ROIs |
---|---|---|---|---|---|---|
Evans | Piccini | 2006 | [11C]raclopride | Dopamine Dysregulation Syndrome |
Acute (levodeopa challenge) | Ventral striatum (+) |
Baseline | None | |||||
Behavioral correlation (disease severitya) | Ventral striatum (pos.) | |||||
Steeves | Strafella | 2009 | [11C]raclopride | Pathological gambling | Acute (gambling task) | Ventral striatum (+) |
Baseline (control task) | Ventral striatum (ICB+<ICB-) | |||||
O’Sullivan | Piccini | 2011 | [11C]raclopride | General ICB | Acute (levodopa + neutral cues) | None |
Acute (levodopa + reward-related cues) | Ventral striatum (+) | |||||
Baseline | None | |||||
Ray | Strafella | 2012 | [11C]FLB-457 | Pathological gambling | Acute (gambling task) | Midbrain (−) |
Baseline (control task) | ACC (ICB+>ICB-) | |||||
Behavioral correlation (state impulsivityb) | Midbrain (pos.) ACC (pos.) | |||||
Payer | Boileau | 2015 | [11C]-(+)-PHNO | General ICB | Baseline | Ventral striatum (ICB+<ICB-) Dorsal striatum (ICB+>ICB-) |
Behavioral correlation (ICB severitya,b) | Ventral striatum (neg.) |
(ICB+>ICB-): indicates baseline D2/3 BPnd increase in ICB+ compared to ICB- subjects
(ICB+<ICB-): indicates baseline D2/3 BPnd decrease in ICB+ compared to ICB- subjects
(+): indicates increased dopamine release in ICB+ subjects
(−): indicates decreased dopamine release in ICB+ subjects
(pos.): indicates positive correlation
(neg.): indicates negative correlation
ACC: anterior cingulate cortex
“wanting” drug (Drug Effects Questionnaire)
Barratt Impulsivity Scale-11